Cargando…
Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective
Chronic kidney disease (CKD) is predominant in 10% of the world’s adult population, and is increasingly considered a silent epidemic. Gut microbiota plays an essential role in maintaining host energy homeostasis and gut epithelial integrity. Alterations in gut microbiota composition, functions and,...
Autores principales: | Lohia, Sonnal, Vlahou, Antonia, Zoidakis, Jerome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951538/ https://www.ncbi.nlm.nih.gov/pubmed/35324673 http://dx.doi.org/10.3390/toxins14030176 |
Ejemplares similares
-
Glycosylation Analysis of Urinary Peptidome Highlights IGF2 Glycopeptides in Association with CKD
por: Lohia, Sonnal, et al.
Publicado: (2023) -
Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment
por: Lohia, Sonnal, et al.
Publicado: (2023) -
PeptiCKDdb—peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease
por: Krochmal, Magdalena, et al.
Publicado: (2016) -
Reviewing the Regulators of COL1A1
por: Devos, Hanne, et al.
Publicado: (2023) -
Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma
por: Makridakis, Manousos, et al.
Publicado: (2020)